Naval Daver, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Gilead
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Servier
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Genentech
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Astellas
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Abbvie
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Immunogen
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Amgen
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Trillium
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Arog
    Date added:
    04/12/2023
    Date updated:
    04/12/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Date added:
    04/12/2023
    Date updated:
    04/12/2023

Pages

Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes